Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation
2025 · 1st Quarter (Jan 1 - Mar 31)
QUEST DIAGNOSTICS INCORPORATED
Filed by QUEST DIAGNOSTICS INCORPORATED.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Amendment
- Posted
- Jan 20, 2026
- Income
- Not reported
- Expenses
- $330,000.00
- Registrant
- QUEST DIAGNOSTICS INCORPORATED
- Filing UUID
- 5bc1f1cf-3fcf-4456-864c-417e0a4bf678
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
Literal federal measure citations: H.R. 6363
FY 2026 appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.